EMERGENT BIOSOLUT Valuation
| ER4 Stock | EUR 5.25 0.08 1.50% |
At this time, the firm appears to be overvalued. EMERGENT BIOSOLUT shows a prevailing Real Value of €5.12 per share. The current price of the firm is €5.25. Our model computes the value of EMERGENT BIOSOLUT from analyzing the firm fundamentals such as ebitda of (41.1 M), and Price To Sales of 0.42 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that EMERGENT BIOSOLUT's price fluctuation is unstable at this time. Calculation of the real value of EMERGENT BIOSOLUT is based on 3 months time horizon. Increasing EMERGENT BIOSOLUT's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EMERGENT stock is determined by what a typical buyer is willing to pay for full or partial control of EMERGENT BIOSOLUT. Since EMERGENT BIOSOLUT is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EMERGENT Stock. However, EMERGENT BIOSOLUT's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.25 | Real 5.12 | Hype 5.33 | Naive 6.12 |
The real value of EMERGENT Stock, also known as its intrinsic value, is the underlying worth of EMERGENT BIOSOLUT Company, which is reflected in its stock price. It is based on EMERGENT BIOSOLUT's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of EMERGENT BIOSOLUT's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of EMERGENT BIOSOLUT helps investors to forecast how EMERGENT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EMERGENT BIOSOLUT more accurately as focusing exclusively on EMERGENT BIOSOLUT's fundamentals will not take into account other important factors: EMERGENT BIOSOLUT Total Value Analysis
EMERGENT BIOSOLUT is currently forecasted to have takeover price of 1.34 B with market capitalization of 1.91 B, debt of 448.5 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EMERGENT BIOSOLUT fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.34 B | 1.91 B | 448.5 M |
EMERGENT BIOSOLUT Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of EMERGENT indicates not a very effective usage of assets in March.EMERGENT BIOSOLUT Profitability Analysis
The company reported the revenue of 1.12 B. Net Loss for the year was (223.8 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates EMERGENT BIOSOLUT's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in EMERGENT BIOSOLUT and how it compares across the competition.
About EMERGENT BIOSOLUT Valuation
The stock valuation mechanism determines EMERGENT BIOSOLUT's current worth on a weekly basis. Our valuation model uses a comparative analysis of EMERGENT BIOSOLUT. We calculate exposure to EMERGENT BIOSOLUT's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EMERGENT BIOSOLUT's related companies.8 Steps to conduct EMERGENT BIOSOLUT's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates EMERGENT BIOSOLUT's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct EMERGENT BIOSOLUT's valuation analysis, follow these 8 steps:- Gather financial information: Obtain EMERGENT BIOSOLUT's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine EMERGENT BIOSOLUT's revenue streams: Identify EMERGENT BIOSOLUT's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research EMERGENT BIOSOLUT's industry and market trends, including the size of the market, growth rate, and competition.
- Establish EMERGENT BIOSOLUT's growth potential: Evaluate EMERGENT BIOSOLUT's management, business model, and growth potential.
- Determine EMERGENT BIOSOLUT's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate EMERGENT BIOSOLUT's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for EMERGENT Stock analysis
When running EMERGENT BIOSOLUT's price analysis, check to measure EMERGENT BIOSOLUT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMERGENT BIOSOLUT is operating at the current time. Most of EMERGENT BIOSOLUT's value examination focuses on studying past and present price action to predict the probability of EMERGENT BIOSOLUT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMERGENT BIOSOLUT's price. Additionally, you may evaluate how the addition of EMERGENT BIOSOLUT to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |